Plexus chairman sells 10,000 shares, gets RSUs

Plexus Corp. chairman Dean A. Foate, a director and Chairman of the Board, reported insider transactions in Plexus Corp. common stock.

Rhea-AI Filing Summary

Plexus Corp. chairman Dean A. Foate, a director and Chairman of the Board, reported insider transactions in Plexus Corp. common stock.

On February 6, 2026, he sold 10,000 shares of common stock at $205 per share, leaving him with 99,429 shares held directly. He also has 15,000 shares held indirectly in a trust for which he is trustee.

Separately, on February 9, 2026, he received a grant of 1,008 Restricted Stock Units under the Plexus Corp. 2024 Omnibus Incentive Plan. Each unit represents one share of common stock and these units vest on February 9, 2027.

Insider Trade Summary

Net Seller: 10,000 shares

Net Sell 3 txns

Insider FOATE DEAN A

Role Director

Sold 10,000 shs ($2.05M)

Type	Security	Shares	Price	Value
Grant/Award	Restricted Stock Units	1,008	$0.00	$0.00
Sale	Common Stock, $.01 par value	10,000	$205.00	$2.05M
holding	Common Stock, $.01 par value	--	--	--

Holdings After Transaction: Restricted Stock Units — 1,008 contracts (Direct); Common Stock, $.01 par value — 99,429 shares (Direct); Common Stock, $.01 par value — 15,000 shares (Indirect, Trust)

Footnotes (2)

1. F1. Shares of Plexus Corp. common stock held in a trust for which the reporting person is a trustee.
2. F2. Each Restricted Stock Unit granted under the Plexus Corp. 2024 Omnibus Incentive Plan, which qualifies under Rule 16b-3, represents a contingent right to receive one share of Plexus Corp. common stock. The Restricted Stock Units vest on February 9, 2027.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did Plexus (PLXS) report for Dean A. Foate?

Dean A. Foate reported selling 10,000 Plexus common shares at $205 and receiving 1,008 Restricted Stock Units. After these transactions, he held 99,429 shares directly and 15,000 shares indirectly through a trust where he serves as trustee.

How many Plexus (PLXS) shares does Dean A. Foate own after this Form 4?

After the reported transactions, Dean A. Foate beneficially owned 99,429 Plexus common shares directly and 15,000 shares indirectly through a trust. He also held 1,008 Restricted Stock Units that each represent a right to receive one share upon vesting.

What was the sale price for Dean A. Foate’s Plexus (PLXS) shares?

Dean A. Foate sold 10,000 shares of Plexus common stock at $205 per share. The transaction was reported as a direct disposition of shares and left him with 99,429 directly held shares after the sale was completed.

What are the terms of the 1,008 Restricted Stock Units granted to Dean A. Foate at Plexus (PLXS)?

Foate received 1,008 Restricted Stock Units under the Plexus Corp. 2024 Omnibus Incentive Plan. Each unit represents a contingent right to one Plexus common share, and the units are scheduled to vest on February 9, 2027, if plan conditions are satisfied.

How are Dean A. Foate’s indirect Plexus (PLXS) holdings structured?

Foate’s indirect Plexus holdings consist of 15,000 common shares held in a trust. The filing notes that he is a trustee of this trust, indicating those shares are reported as indirectly beneficially owned through the trust structure.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/10/2026 - 04:50 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

FOATE DEAN A

(Last) (First) (Middle)

ONE PLEXUS WAY

(Street)

NEENAH WI 54956

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
PLEXUS CORP [ PLXS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)	X	Other (specify below)
			Chairman of the Board

3. Date of Earliest Transaction (Month/Day/Year)
02/06/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, $.01 par value								15,000	I	Trust(1)
Common Stock, $.01 par value	02/06/2026		S		10,000	D	$205	99,429	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	(2)	02/09/2026		A		1,008		(2)	(2)	Common Stock, $.01 par value	1,008	(2)	1,008	D

Explanation of Responses:

1. Shares of Plexus Corp. common stock held in a trust for which the reporting person is a trustee.

2. Each Restricted Stock Unit granted under the Plexus Corp. 2024 Omnibus Incentive Plan, which qualifies under Rule 16b-3, represents a contingent right to receive one share of Plexus Corp. common stock. The Restricted Stock Units vest on February 9, 2027.

Remarks:

	/s/ Dean A. Foate, by Kate A. Gitter, Attorney-in-Fact	02/10/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.